natural treatments for autoimmune diseases

GRI Bio, Inc. (NASDAQ: GRI), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, ... Nature: One woman, three autoimmune diseases: CAR-T therapy vanquishes ultra-rare disease trio The Des Moines Register: PlacidWay Expands ITC Tijuana Partnership to Advance Natural Cancer and Chronic Disease Treatments PlacidWay Expands ITC Tijuana Partnership to Advance Natural Cancer and Chronic Disease Treatments Nasdaq: Cabaletta Bio Reports Promising Clinical Results from RESET Trials for Autoimmune Diseases at EULAR 2025 Cabaletta Bio, Inc.

Understanding the Context

announced promising results from its ongoing RESET clinical trials for its investigational therapy rese-cel, focusing on autoimmune diseases. In the trials, notable outcomes ... Cabaletta Bio Reports Promising Clinical Results from RESET Trials for Autoimmune Diseases at EULAR 2025 Autoimmune diseases are a group of diverse and complex disorders that arise from misrecognition of self-antigens by the immune system. These diseases can involve immune cells, cytokines and protein ...